How to Buy Repligen Stock

Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.

Repligen stock last closed at $130.00, down 1.59% from the previous day, and has decreased 19.24% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.08 percentage points. Repligen stock is currently +26.26% from its 52-week low of $102.97, and -28.77% from its 52-week high of $182.52.

As of Apr 17, 2025, there are 56.15M shares of RGEN outstanding. The market capitalization of RGEN is $7.30B. In the last 24 hours, 754,658 RGEN shares were traded.

How to Buy Repligen Stock

Not sure how to invest in Repligen stock? Here's how.

  1. Choose where to buy Repligen stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Repligen stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Pick your method of payment and add your info.
  4. Research Repligen stock: The Repligen ticker symbol is RGEN. Is Repligen stock a good investment? Should you buy shares of RGEN? How do RGEN's underlying business fundamentals look? Do top analysts think Repligen is a good buy? Why has RGEN's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if RGEN is a good stock to buy).
  5. Place your RGEN buy order: Decide if you will purchase RGEN shares at the current market price or use a limit order to buy RGEN stock at a given price.
  6. Get the latest scoop on your RGEN position: Create a watchlist to get the latest news on your position in Repligen shares.

Step 1: Choose where to buy Repligen stock

You need a brokerage account in order to access the NASDAQ market and buy RGEN stock.

A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our research, eToro is the best brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in RGEN today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to create your new brokerage account.
  1. Send your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've finished signing up on the best app for stock investing, your next step is to transfer the money for your investment:

Watch this video walkthrough if you need help transferring funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Repligen stock

After you have selected the best place to buy Repligen stock, it's important to analyze their stock before you invest, so you actually comprehend the risk and upside.

Repligen Numbers

RGEN Price
$130.00
1w %
12.86%
1y %
-19.24%
5y %
23.09%
P/E
-282.61x
P/B
3.7x
P/S
11.46x
PEG
N/A
Revenue
$634.44M
Earnings
-$25.51M
Fore. Rev. Growth
14.04%
Fore. Earn. Growth
N/A
Market Cap
$7.30B
Next Earnings
Apr 29, 2025
Next Dividend
N/A

RGEN Due Diligence Score

WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis.

You can see all of the due diligence checks on RGEN's stock page.

What is the fair value of RGEN stock?

Analysts use many financial metrics, analyses, models, and charts to gauge RGEN's fair value.

Using relative valuations methods:

  • RGEN may be overvalued based on its P/B ratio of 3.7x, relative to Medical Instruments & Supplies industry P/B ratio of 3.55x

You can access more valuation analysis on RGEN's stock here.

RGEN Financial Health Summary

Pros:

  • RGEN's operating cash flow of $175.39M allows it to safely service it's debt of $686.25M.
  • There are more short-term assets than short-term liabilities on the RGEN balance sheet.
  • There are more short-term assets than long-term liabilities on the RGEN balance sheet.

Cons:

  • RGEN profit margin has gone down from 5.6% to -4% in the past year.
  • RGEN has a relatively high debt to equity ratio of 0.43.
  • RGEN earnings of -$6.30M is not sufficient to cover its interest payments.
  • Total RGEN debt is higher than 5 years ago, relative to shareholder equity.

Is it a good time to buy Repligen stock, according to analysts?

Out of 5 Wall Street analysts who track RGEN, the consensus analyst rating on RGEN is a Buy

Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Repligen stock forecast page.

RGEN Momentum

SMA10
121.48
SMA20
128.01
SMA50
142.61
SMA100
148.52
SMA200
145.31
MACD
-5.09
MACD Signal
-6.93
MACD Histogram
1.83
RSI
48.6
Stochastic %K
76.72
Stochastic %D
67.74
StochRSI %K
97.23
StochRSI %D
98.63

Is RGEN Growing Revenue?

Last year, RGEN revenue was $634.44M. Over the past 5 year, RGEN's revenue has grown by 18.61% per year. This was faster than the Medical Instruments & Supplies industry average of 8.99%.

Find out more about RGEN's earnings and revenue performance here.

Are RGEN insiders buying or selling the stock?

Over the last 12 months, insiders at RGEN have sold more shares than they have bought.

James Bylund, Chief Operating Officer of RGEN, was the latest RGEN insider to sell. They sold $58,339.00 worth of RGEN shares on Apr 1, 2025.

Get more info about who owns RGEN shares here.

Can I rely on RGEN as an income stream?

No, Repligen doesn't provide an income stream by paying out dividends.

What do other investors have to say about RGEN?

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Place your RGEN buy order

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly the best for newer investors.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a given dollar amount, place a limit order.

Click the Open Trade button and your broker will place your order.

If you want additional assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest scoop on your RGEN position

Now that you own some RGEN stock, you'll want to stay up-to-date on your stock purchase.

Make a watchlist to get the latest updates about your RGEN stock.

RGEN Feed

How to Buy Stock in Repligen

To summarize, here are the 6 steps to buy Repligen stock:

  1. Choose where to buy Repligen stock
  2. Sign up for your brokerage account
  3. Deposit funds into your investment account
  4. Research Repligen stock
  5. Place your RGEN buy order
  6. Get the latest scoop on your RGEN position

If you require a brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest news on your new investment in Repligen, create your watchlist below.

NASDAQ: RGEN
$130.00-2.10 (-1.59%)
Updated Apr 17, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: RGEN
$130.00-2.10 (-1.59%)
Updated Apr 17, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Repligen share?

As of Apr 17, 2025, it costs $130.00 to buy one share of Repligen stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.077 shares of RGEN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Repligen stock?

According to 5 Wall Street analysts who monitor Repligen, their consensus recommendation is to buy Repligen stock.

What is the best way to buy Repligen stock?

One way to place an order for Repligen stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.